FIELD: medicine.
SUBSTANCE: invention refers to biotechnology. There is described a vaccine composition applicable for cancer treatment and containing: one or more versions of peptide fragments prepared of survivin protein where specified peptide fragment is chosen from the group consisting of: FTELTLGEF (SEQ ID NO: 16), LMLGEFLKL (SEQ ID NO: 5), EPDLAQCFY (SEQ ID NO: 9), APPAWQPFL (SEQ ID NO: 13) and RPPAWQPFL (SEQ ID NO: 14), and an adjuvant made as "water-in-oil" emulsion containing mineral oil and surface-active substance where said adjuvant contains to 14.5 vol. % of specified surface-active substance. There is offered a method for strong specific T-cell survivin response stimulation in a person, including introduction of the described vaccine, and also a method of cancer treatment or prevention in a person, including introduction of the described vaccine.
EFFECT: vaccine can be applied for preventive, relieving and/or medicinal treatment of eg oncological diseases.
14 cl, 3 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| Bcl-2 PROTEINS, FRAGMENTS THEREOF, AND APPLICATION THEREOF IN PATIENTS WITH MALIGNANT TUMOUR | 2004 |
|
RU2367468C2 |
| VACCINATIVE TUMOR VACCINE COMPOSITION | 2008 |
|
RU2682726C2 |
| VACCINE COMPOSITION FOR MALIGNANT TUMOR | 2013 |
|
RU2721574C2 |
| PEPTIDE VACCINES FOR CANCER EXPRESSING MPHOSPH1 OR DEPDC1 POLYPEPTIDES | 2007 |
|
RU2469044C2 |
| URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME | 2015 |
|
RU2700881C2 |
| KOC1-DERVIED PEPTIDE AND VACCINE INCLUDING SAME | 2015 |
|
RU2699542C2 |
| CDCA1-DERIVED PEPTIDE AND VACCINE CONTAINING SAME | 2015 |
|
RU2699543C2 |
| CDC45L PEPTIDES AND VACCINES CONTAINING SAME | 2010 |
|
RU2562160C2 |
| COMPOSITION FOR TREATING LUNG CANCER, FIRST NON-SMALL CELLS LUNG CANCER (NSCLC) | 2008 |
|
RU2526510C2 |
| HELPER PEPTIDE FOR CANCER ANTIGEN | 2010 |
|
RU2588442C2 |
